Dr. Henrik Harling

2cureX

Henrik Harling is an experienced surgeon within colorectal cancer and is Chief Business Officer at
2cureX. Dr. Harling is one of the founders of the Danish Colorectal Cancer Group (DCCG) in
Denmark and served as Chairman from 1994 to 2010. The DCCG develops and implements
guidelines for colorectal cancer treatment and is involved in deciding on implementation of new
diagnostic technologies in Denmark.

dont miss

IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients

Overview presentation that will provide insight in the importance of Functional Profiling of solid tumors in order to match individual cancer patients with an effective treatment design. 2cureX manufactures the IndiTreat® test which is currently available for Colorectal cancer.

EVEN MORE SEMINARS

  • Dr. Henrik Harling: Speaking at the Oncology Convention

    Dr. Henrik Harling
    2cureX

    IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients

  • Neil Oakley: Speaking at the Oncology Convention

    Neil Oakley
    Sheffield Teaching Hospitals NHS Trust

    Robotic Radical Prostatectomy for Prostate cancer aiming for Trifecta 2020

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers